使用ACE2的早期融合中间体作为抗病毒点

Lixiao Xing1, Zhimin Liu1, Xinling Wang1

  • 1Shanghai Institute of Infectious Disease and Biosecurity, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Fifth People's Hospital, Institutes of Biomedical Sciences, Shanghai Public Health Clinical Center, Shanghai Medical College, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, Fudan University, Shanghai 200032, China.

Cell
|January 31, 2025
PubMed
概括

科学家在进入宿主细胞时发现了SARS-CoV-2尖端蛋白的新中间状态. 这一发现导致开发了一种双功能的抗病毒蛋白,AL5E,对使用ACE2的冠状病毒有效.